Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2022-08-17
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Empowerment Intervention for Persons With Young Onset Dementia
NCT02937883
Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research
NCT07016178
Family Involvement Hospital Ethnography
NCT06374992
Development, Optimization, Efficiency of the Interface System of Communication and Control of the Environment
NCT03361696
SHARE(D) Stage II: Alzheimer's Risk Disclosure Protocol Piloting
NCT04309500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with AD or mild cognitive impairment due to AD
All three 'arms' take part in a focus group or interview. The conversation topics will be the same (with the aim to gauge interpretations / needs / thoughts / feelings with regard data usage for research and the role health data engagement interfaces (Dynamic Consent) may play in this.
Showing an existing Dynamic Consent (computer interface) as prompt
An existing Dynamic Consent interface will be shown as a prompt halfway through the focus group sessions.
Informal carers of patients with AD or mild cognitive impairment due to AD
All three 'arms' take part in a focus group or interview. The conversation topics will be the same (with the aim to gauge interpretations / needs / thoughts / feelings with regard data usage for research and the role health data engagement interfaces (Dynamic Consent) may play in this.
Showing an existing Dynamic Consent (computer interface) as prompt
An existing Dynamic Consent interface will be shown as a prompt halfway through the focus group sessions.
Dementia experts/specialists
Given their expertise on dementia from a professional point of view, a focus group is conducted with dementia specialists in order to elicit their views and ideas on health data engagement interface like Dynamic Consent.
Showing an existing Dynamic Consent (computer interface) as prompt
An existing Dynamic Consent interface will be shown as a prompt halfway through the focus group sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Showing an existing Dynamic Consent (computer interface) as prompt
An existing Dynamic Consent interface will be shown as a prompt halfway through the focus group sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mild cognitive impairment due to AD (diagnosed according to the NIA/AA diagnostic criteria)
* mild dementia due to AD (diagnosed according to the NIA/AA diagnostic criteria)
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lawrence Van den Bogaert, Master's
Role: PRINCIPAL_INVESTIGATOR
VUB (Vrije Universiteit Brussel)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel (UZB)
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Engage 2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.